Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lipocine (LPCN)
NASDAQ:LPCN
Holding LPCN?
Track your performance easily
LPCN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.31 - $11.79
Previous Close$4.83
Volume89.17K
Average Volume (3M)38.85K
Market Cap
$25.83M
Enterprise Value$3.28M
Total Cash (Recent Filing)$22.55M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Nov 06, 2024EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.61
Shares Outstanding5,347,940
10 Day Avg. Volume52,955
30 Day Avg. Volume38,851
Standard Deviation0.24
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.21
Price to Sales (P/S)5.29
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit-1.15
Enterprise Value/Ebitda-0.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lipocine News
PremiumCompany Announcements
Lipocine Sets Employee Bonuses and Expands Stock Plan
PremiumCompany Announcements
Lipocine Initiates New ATM Offering, Ends Previous AgreementRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LPCN FAQ
What was Lipocine’s price range in the past 12 months?
Lipocine lowest stock price was $2.31 and its highest was $11.79 in the past 12 months.
What is Lipocine’s market cap?
Currently, no data Available
When is Lipocine’s upcoming earnings report date?
Lipocine’s upcoming earnings report date is Nov 06, 2024 which is in 49 days.
How were Lipocine’s earnings last quarter?
Lipocine released its earnings results on Aug 08, 2024. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.78 by $0.22.
Is Lipocine overvalued?
According to Wall Street analysts Lipocine’s price is currently Overvalued.
Does Lipocine pay dividends?
Lipocine does not currently pay dividends.
What is Lipocine’s EPS estimate?
Lipocine’s EPS estimate is -$0.38.
How many shares outstanding does Lipocine have?
Lipocine has 5,347,940 shares outstanding.
What happened to Lipocine’s price movement after its last earnings report?
Lipocine reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.78. Following the earnings report the stock price went down -12.897%.
Which hedge fund is a major shareholder of Lipocine?
Currently, no hedge funds are holding shares in LPCN
---
Lipocine Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.69%
12-Months-Change
Fundamentals
Return on Equity
-34.12%
Trailing 12-Months
Asset Growth
-24.44%
Trailing 12-Months
Company Description
Lipocine
Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.
---
LPCN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Eton Pharmaceuticals
―
Aclaris Therapeutics
―
Ovid Therapeutics
―
Viking Therapeutics
―
Best Analysts Covering LPCN
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-13.08%
reiterated a buy rating 10 months ago
Copying Matthew Kaplan's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -13.08% per trade.
---